Strides Pharma Science Q4 Results

  • BSE: 532531
  • NSE: STAR
  • ISIN: INE939A01011
  • Sector: Biotechnology & Drugs
BSE
1,419.15-84.60 (-5.63%)
Volume17.28 K
Updated: Mon 25 Nov, 2024 | 15:47:42
NSE
1,417.45-86.80 (-5.77%)
Volume5.63 L
Updated: Mon 25 Nov, 2024 | 15:44:11
Today: 1,394.05
1,529.80
52-Wk: 482.50
1,675.25

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Strides Pharma Science Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 1,084.04864.85-%986.37-%
    Selling/ General/ Admin Expenses Total 199.17181.01-%175.66-%
    Depreciation/ Amortization 49.7660.22-%60.93-%
    Other Operating Expenses Total 238.91200.00-%254.45-%
    Total Operating Expense 912.13767.16-%899.08-%
    Operating Income 171.9097.68-%87.29-%
    Net Income Before Taxes 29.62-78.02-%-6.71-%
    Net Income 18.18-80.03-%-9.54-%
    Diluted Normalized EPS 2.53-11.85-%-0.53-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts